10/31/14 SUI 57.97 Sun Communities $SUI Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
10/31/14 SUI 57.97 Sun Communities $SUI Hit a 52 week high of 57.99 Closing the day 10/31/14 at 57.97 +2.13 +3.81% With a day low of 55.56 and a total volume of 342,700.

SUI Recent Posts: http://investorshangout.com/Sun-Communities-SUI-52750/

STE Steris Corp Recent Headline News

35.7% Return Seen to Date on SmarTrend STERIS Call (STE)
Comtex SmarTrend(R) - Fri Oct 31, 4:36PM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 9 months, STERIS has returned 35.69% as of today's recent price of $61.80.
STE: 61.80 (+0.96)

DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 30.04 (+0.11), STE: 61.80 (+0.96), HSIC: 120.03 (-0.18), XRAY: 50.77 (+0.68)

STERIS Corporation to Announce Fiscal 2015 Second Quarter Financial Results on November 5, 2014
Thomson Reuters ONE - Tue Oct 28, 8:49AM CDT
Mentor, Ohio (October 28, 2014) - STERIS Corporation (NYSE: STE) today announced that it will release its fiscal 2015 second quarter financial results before the market opens on November 5, 2014, followed by a conference call at 10:00 a.m. Eastern Standard Time. The conference call can be heard live over the Internet at www.steris-ir.com or via phone by dialing 1- 800-369-8428 in the United States and Canada, or 1-773-799-3378 internationally, then referencing the password "STERIS".
STE: 61.80 (+0.96)

CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 61.80 (+0.96), CNMD: 41.99 (-0.05), COO: 163.90 (+0.24)

STERIS Shares Up 31.5% Since SmarTrend's Buy Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 24, 10:57AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 31.53% as of today's recent price of $59.90.
STE: 61.80 (+0.96)

NYSE stocks posting largest percentage increases
AP - Thu Oct 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
CRS: 50.05 (+2.05), UFS: 41.07 (+1.28), CLV: 10.50 (+0.27), BBW: 16.95 (+0.06), CLF: 11.23 (+0.73), MTRN: 39.45 (+1.58), XRS: 31.76 (+0.04), GPI: 85.43 (+1.34), STE: 61.80 (+0.96), BRP: 23.25 (-0.05), TYL: 111.92 (+1.50), FUN: 47.26 (+0.30), UIS: 25.64 (+0.50), SIX: 40.30 (+0.08), TLLP: 56.30 (-0.34)

After Yesterday's Rally of 4.02% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:01PM CDT
STERIS (NYSE:STE) traded in a range yesterday that spanned from a low of $56.97 to a high of $59.21. Yesterday, the shares gained 4.0%, which took the trading range above the 3-day high of $56.87 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
STE: 61.80 (+0.96)

Upgrade Alert for STERIS (STE)
Comtex SmarTrend(R) - Wed Oct 22, 6:55AM CDT
STERIS (NYSE:STE) was upgraded from Market Perform to Strong Buy at Raymond James today. The stock closed yesterday at $56.68 on volume of 484,000 shares, below average daily volume of 545,000. STERIS (NYSE:STE) has potential upside of 9.1% based on a current price of $56.68 and analysts' consensus price target of $61.83. The stock should find initial support at its 50-day moving average (MA) of $55.58 and further support at its 200-day MA of $51.36.
STE: 61.80 (+0.96)

Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 61.80 (+0.96), CAH: 78.48 (+0.29), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)

Why STERIS (STE) Stock Is Gaining in Pre-Market Trading Today
at The Street - Mon Oct 13, 8:03AM CDT
STERIS (STE) stock is rising in pre-market trading after announcing it will purchase the U.K's Synergy Health for $1.9 billion in cash and stock.
STE: 61.80 (+0.96)

Steris to spend $1.9B on UK's Synergy Health
By TOM MURPHY - AP - Mon Oct 13, 7:03AM CDT
Steris Corp. will spend about $1.9 billion to buy a British sterilization services company, as U.S. businesses continue to seek overseas incorporations despite attempts to make such tax-saving maneuvers less lucrative.
MDT: 68.16 (+0.73), STE: 61.80 (+0.96), COV: 92.44 (+0.83)

European Stocks, Asian Shares Trade Mixed in Bumpy Trading
at The Street - Mon Oct 13, 5:46AM CDT
International markets are mixed early Monday.
STE: 61.80 (+0.96), LUX: 50.80 (+0.16), STO: 22.95 (-0.21)

STERIS to Acquire Synergy Health for $1.9 Billion in Cash and Stock
Thomson Reuters ONE - Mon Oct 13, 3:02AM CDT
Combination Creates a Global Leader in Infection Prevention and Sterilization
STE: 61.80 (+0.96)

STERIS Has Returned 27.4% Since SmarTrend Recommendation (STE)
Comtex SmarTrend(R) - Fri Oct 10, 9:54AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.54. In approximately 8 months, STERIS has returned 27.39% as of today's recent price of $58.02.
STE: 61.80 (+0.96)

Shares of STE Up 19.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Oct 03, 9:21AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 8 months, STERIS has returned 19.22% as of today's recent price of $54.30.
STE: 61.80 (+0.96)

Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)

23.2% Return Seen to Date on SmarTrend STERIS Call (STE)
Comtex SmarTrend(R) - Thu Sep 11, 10:07AM CDT
SmarTrend identified an Uptrend for STERIS (NYSE:STE) on February 18th, 2014 at $45.55. In approximately 7 months, STERIS has returned 23.17% as of today's recent price of $56.10.
STE: 61.80 (+0.96)

Sun Communities Inc. (SUI) Stock Research Links

SUI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 8

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 6

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 5

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Updated Category News Views 6

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 7

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Alcresta Therapeutics Initiates Patient Enrollment for RELiZORB Trial

Updated Category News Views 134

Alcresta Therapeutics Engages in Groundbreaking Clinical Trials Alcresta Therapeutics, Inc. is at the forefront of innovation in medical care, particularly in the realm of enzyme-based products. Recently, the company made an exciting announcement regarding its investigator-initiated trial at Inova Fairfax Medical Campus, which has just enrolled its first patient. This...

Continue Reading
Kaskela Law LLC Investigates Blue Ridge Bankshares Shareholders

Updated Category News Views 47

Kaskela Law LLC Investigates Blue Ridge Bankshares Shareholders Kaskela Law LLC is making headlines as it launches an investigation into Blue Ridge Bankshares, Inc. (NYSE: BRBS). This investigation is particularly focused on long-term shareholders of Blue Ridge, who may have suffered due to recent issues related to the company's financial reporting and practices....

Continue Reading
Exploring Net Asset Value for Octopus AIM VCT 2 plc Shares

Updated Category News Views 158

Understanding Net Asset Value When it comes to investments, especially in publicly traded companies, understanding net asset value (NAV) is critical. For Octopus AIM VCT 2 plc, the recent reports indicate that the NAV stands at approximately 37.3 pence per Ordinary share. This figure is essential for current and potential investors as it provides insight into the...

Continue Reading
Banzai Welcomes Michael Kurtzman as New Chief Revenue Officer

Updated Category News Views 230

Banzai Appoints Michael Kurtzman as Chief Revenue Officer Veteran Revenue and Go-to-Market Executive to Scale Leading Video Engagement, Production, and Webinar Solutions Introduction of Michael Kurtzman SEATTLE — Banzai International, Inc. (NASDAQ: BNZI), a prominent marketing technology company, is thrilled to announce Michael Kurtzman has joined the team as the new...

Continue Reading
FibroBiologics Secures $1.5 Million in Direct Stock Offering

Updated Category News Views 122

FibroBiologics Closes Successful Funding Round FibroBiologics, Inc. (NASDAQ: FBLG), a prominent clinical-stage biotechnology firm, has successfully finalized a registered direct offering valued at $1.5 million. This notable transaction underscores the company's commitment to advancing its research and development initiatives centered around chronic disease therapeutics....

Continue Reading